Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Avalanche Biotech's stock loses half its value after trial results raise concerns
Avalanche Biotech's stock loses half its value after trial results raise concerns
Avalanche Biotech's stock loses half its value after trial results raise concerns
Submitted by
admin
on June 16, 2015 - 9:11am
Source:
Marketwatch
News Tags:
Avalanche Biotechnologies
wet age-related macular degeneration
AVA-101
Headline:
Avalanche Biotech's stock loses half its value after trial results raise concerns
Do Not Allow Advertisers to Use My Personal information
